Second Sight Medical Products has secured Medicare coverage for its Argus II retinal prosthesis system (Argus II) designed to treat the patients affected with blindness from the untreatable orphan disease retinitis pigmentosa in both the US ...
Tags: Government Funding, Medicine
The US Food and Drug Administration (FDA) has cleared Second Sight Medical Products' retinal prosthesis system to treat patients with late stage retinitis pigmentosa (RP). The CE-marked Argus II retinal prosthesis system, which the ...
The Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel has scheduled to review the data presented in the Second Sight Medical Products' humanitarian device exemption (HDE) market approval application, for its Argus II ...
Tags: FDA, Argus II System, medical technology